MJHID publishes topical reviews and original articles related to the diagnosis, management, and research of hematologic and infectious diseases. The content of the MJHID is determined by the Editors.
MJHID, the Publisher, and the Editors of its publications assume no responsibility for the statements expressed by the contributors (and/or authors) of the articles.
The manuscript which is submitted to the journal must not contain previously published material or material under consideration for publication elsewhere. Accepted manuscripts become the property of MJHID and may not be republished.
All manuscripts will undergo peer review. A final review and a subsequent decision relative to publication will then be made by an MJHID editor.
Responsibilities of the Authors
By submitting a manuscript for publication, each author acknowledges having made a substantial contribution to:
- The conception and design of the study.
- The analysis and interpretation of the results.
- The writing of the paper.
- And has approved the final submitted version of the paper.
Each author thus also acknowledges responsibility for the integrity of the manuscript, assures the originality of the manuscript, and guarantees that duplicate or redundant publications or submissions have not occurred. The Editors reserve the right to request the original data obtained in the investigation. Authors are responsible for all statements made in the text.
These instructions are based in part on recommendations in the Uniform Requirements for Manuscripts Submitted to Biomedical Journal [Ann. Intern. Med. 1997; 126: 36-47]. Variations from guidelines in this publication reflect the individual style of MJHID.
The authors should submit the manuscript as a complete file. Submit an electronic version of text (as an MS WORD document), unlabeled and labeled images (as JPEG files). The manuscript should be typed in times new roman font, double-spaced throughout on one side of A4/Letter paper with at least a 2.5 cm/1 inch margin on all sides. Number all pages consecutively, beginning with the title page.
There are no restrictions to page counts or number of figures/videos, however, in the interest of readers, we suggest limiting to a 10-12 page maximum. Prepare a cover letter and the author license form (has to be sent via post or fax) signed by all authors.
Organize the manuscript as follows: title page, abstract, introduction, material and methods, results, discussion including a conclusion, acknowledgments, references, figure legends, and tables. Keep acronyms and abbreviations to a minimum. When an acronym is used, define it at first mention and follow with the abbreviation in parentheses.
Categories of Submission
Review Articles and Comments
The author(s) is free to design the paper. No particular form is required for these articles. Moreover, authors should take into consideration the suggestions of PRISMA Group, Shamseer L, Moher D, Clarke M, Ghersi D, Liberati A, Petticrew M, Shekelle P, Stewart LA; PRISMA-P Group. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation. BMJ. 2015;349:g7647. doi: 10.1136/bmj.g7647. http://www.bmj.com/content/349/bmj.g7647.long
Furthermore, they should include an informative, unstructured abstract of about 250 words; we suggest limiting to 10-12 pages (5000-6000 words+references), Mini Reviews (4000 words and <100 references) will also be considered.
References, figures, and legends follow the guidelines described below under Original Articles. The review articles are generally solicited by the Editors, but the journal may also considerer reviews submitted on authors' initiative. However the self-proposing author should be an expert on the field, as documented by peer-reviewed articles, presubmission inquiries are welcome.
Title Page. The following information should appear: the title of the article; authors name, and last name; affiliations, grant support, and presentation in part or whole at any meeting. Identify the corresponding author and provide a full mailing address, phone and fax numbers, and e-mail address.
Abstract. The abstract is limited to 300 words, and should describe the essential aspects of the investigation. In the first sentence state the background; in the second sentence state your specific purpose or hypothesis; in the third, fourth and fifth sentences summarize methods, results and conclusion. No references should be cited.
Introduction. Include brief background information on what has been done in the past in this area and the importance of your investigation. End with a statement of the purpose or hypothesis of the study.
Material and Methods. This section may be divided into subsections if it facilitates reading the paper. The research design, subjects, material used, and statistical methods should be included. Do not mix results and discussion into this section. Do not include manufacturers names unless the specific product is important to the procedures performed, in which case the city and state or country of the manufacturer should also be given. Indicate that informed consent has been obtained from patients who participated in clinical investigations. In animal experimentation, acknowledge that ethical guidelines were followed. When appropriate, indicate that approval was obtained from the institutions review board.
Results. This section may be divided into subsections if it facilitates reading the paper. All results based on methods must be included. If tables and graphic material will ease the understanding of the results, include them. Cite figures to illustrate the findings of the study.
Discussion. Start with limited background information and then discuss the results of the investigation in light of what has been published in the past, the limitations of your study, and potential directions for future research. In an appropriate place, cite figures and graphs. A final conclusion should summarize the major findings of the study and their clinical usefulness.
Acknowledgments. Acknowledgments should appear on a separate page.
References. Section must be double spaced and begin on a separate page. References are numbered consecutively in the order in which they appear in the text. All references must be cited in the text, where numbers are enclosed in [square brackets] on line with the text (not superscript). Papers submitted but not yet accepted for publication should also be cited in the text. Inclusive page numbers ( e.g., 491-492) must be provided for all references. Journal names should be abbreviated according to MeSH. All authors should be listed in references.
Style and punctuation of references
Journal article. [Reference number] Marcucci G, Radmacher MD, Maharry K, Mrózek K, Ruppert AS, Paschka P,Vukosavljevic T, Whitman SP, Baldus CD, Langer C, Liu CG, Carroll AJ, Powell BL,Garzon R, Croce CM, Kolitz JE, Caligiuri MA, Larson RA, Bloomfield CD. MicroRNA expression in cytogenetically normal acute myeloid leukemia.N Engl J Med. 2008 ;358 :1919-28
Book. [Reference number] Noback CR, Demarest RJ. The Human Nervous System. 2nd Ed., New York, McGraw-Hill. 1975; 199-201.
Edited book. [Reference number] Wyngaarden JB. Principles of human genetics. In: Wyngaarden JB, Smith LH, eds. Cecil Textbook of Medicine. 18th Ed., Philadelphia, W. B. Saunders Company. 1988; 146-152.
URL (Web Page). [Reference number] Pantanowitz L, Früh K, Marconi S, Moses AV, Dezube BJ.
Pathology of rituximab-induced Kaposi sarcoma flare. http://www.biomedcentral.com/1472-6890/8/7 (published 23 July 2008)
Format: Author, if available. Title of the page as listed on the site. Address of page (date accessed).
Tables. Each table should be given on a separate page. Each table has a short, descriptive title. Tables are numbered in the order cited in the text. Abbreviations are defined as footnotes at the bottom of each table. Tables should not duplicate data given in the text or figures.
Figures and Legends. The complete sets of original figures must be submitted. Legends should be in the present tense (e.g., 'Illustration shows ...'). Subjects' names must not appear on the figures. Labels should contrast well with the background. Images should be uniform in size and magnification. Illustrations should be free of all identifying information about the subject and institution. Line drawings should be professional in quality. Written permission for use of all previously published illustrations must be included with submission, and the source should be referenced in the legends. Written permission from any person recognizable in a photo is required. Legends must be double spaced, and figures are numbered in the order cited in the text. Submit color prints only if the color is essential in understanding the material presented. Label all pertinent findings.
Scientific Letters: Important new findings can be published in a format that fit a letter. Start the letter with a paragraph summarizing the rationale for the study and the major conclusions. The initial statement of this paragraph will be utilized as abstract and headlines. Scientific Letters have a maximum of 1500 words in the text (excluding title, affiliations, figures legends or references), a maximum of 3 tables and/or figures, and only 15 essential references. Letters will appear in the table of contents, have a DOI and be indexed in PubMed.
MJHID Educational Clinical Cases
This section contains case studies of particular diagnostic difficulty and therapeutic interest. The diagnostic procedure should be represented step by step. The iconography must be complete and original. The diagnostic tool should be updated or adapted to local conditions. Differential diagnosis should be an important point to consider. Number of pages and references are at the discretion of the authors(in general not more of 3000 words and 30 references)
Letters to the Editor
Letters to the Editor may be used in primis to comment articles appeared in MJHID and to give an opinion or suggestions relative to topics recently treated in the MJHID. Letters should be no more than 3 pages and should be submitted with a brief title. A maximum of 8 references may be included. Letters are published at the discretion of the journal and are subject to editing. Case reports could be submitted as a letter to the editor only when referring to articles appeared in MJHID.
Case reports will be taken into consideration only when they expand the field of general medical knowledge and/or present original research. The rarity of the case is not regarded as a criterium of priority; they will be published in different sections. Case reports when well documented and having a prevalent educational character will be assigned to the section MJHID Educational Clinical Cases, when in strict relationship with previously published full papers in MJHID to the Letter to Editor and if giving important new findings to the pathophysiology of the disease to the Scientific Letter section.
Books for Review
Publishers and authors who wish to have their titles considered for review should send review copies to . Unsolicited book reviews are not considered
The submission file is in Microsoft Word, RTF, or WordPerfect document file format.
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Transfer of Copyright and Permission to Reproduce Parts of Published Papers. Authors will grant copyright of their articles to the Institute of Hematology, Catholic University, Rome. No formal permission will be required to reproduce parts (tables or illustrations) of published papers, provided the source is quoted appropriately and reproduction has no commercial intent. Reproductions with commercial intent will require written permission and payment of royalties.
Reviewing Process: The articles are reviewed by two external reviewers and/or by the Editor in Chief/Guest Editor or a member of the Editorial Board. Authors can suggest 2 or more reviewers; moreover, in any case, the Editor in Chief or/and the Guest Editor will peer review all the manuscripts. Furthermore, two reviewers will be consulted. If the reviewers are in disagreement, a third reviewer will be asked. In any case, the final decision will be made by the editor. The first decision will be taken within six weeks. If the author is unhappy with the decision, he can propose an independent reviewer, with proved experience in the field (Publications in peer review journals).
Publication Charges: Starting from 1-1-2019, all articles, excluding Reviews by invited authors, will be processed after receiving a signed declaration by the authors they undertake to pay a fee of 600,00 € (+ VAT, if any) in case of acceptance for publication. The Article Processing Charges will have to be paid to the Publisher; instructions are given in the Journal’s Guidelines (https://mattiolihealth.com/shop/publication-fee-mediterranean-journal-of-hematology-and-infectious-diseases/) The Editorial Board of the Mediterranean Journal of Hematology and Infectious Diseases is engaged in improving the quality of the papers published in our journal. So, with the agreement of the Publisher, the possibility of publishing in MJHID without charge will be extended to the authors of the five papers which obtained the most citations which contributed to Impact Factor of the year throughout the two years following.